Uncategorized

UK Stocks That Might Be Trading Below Estimated Fair Value

The United Kingdom’s stock market, as reflected by the FTSE 100, has recently faced downward pressure due to weak trade data from China, highlighting the interconnectedness of global economies and their impact on domestic indices. In such a climate, identifying stocks that may be trading below their estimated fair value can present opportunities for investors seeking potential upside in undervalued assets amidst broader market challenges.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

Name

Current Price

Fair Value (Est)

Discount (Est)

Tristel (AIM:TSTL)

£4.125

£7.63

45.9%

Playtech (LSE:PTEC)

£3.596

£6.70

46.3%

Oxford Biomedica (LSE:OXB)

£6.18

£12.25

49.5%

Mitie Group (LSE:MTO)

£1.731

£3.40

49.2%

Marks and Spencer Group (LSE:MKS)

£3.202

£6.18

48.2%

Fevertree Drinks (AIM:FEVR)

£7.78

£14.94

47.9%

Entain (LSE:ENT)

£5.324

£10.06

47.1%

Convatec Group (LSE:CTEC)

£2.08

£4.14

49.8%

B90 Holdings (AIM:B90)

£0.023

£0.045

49.4%

Advanced Medical Solutions Group (AIM:AMS)

£2.47

£4.87

49.3%

Click here to see the full list of 60 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Overview: Cohort plc operates in the defense, security, and related markets across multiple regions including the United Kingdom, Germany, Portugal, Australia, the Americas, Asia Pacific, Africa, and Europe with a market cap of £514.85 million.

Operations: The company’s revenue is primarily derived from its Sensors and Effectors segment, generating £147.78 million, and its Communications and Intelligence segment, contributing £132.04 million.

Estimated Discount To Fair Value: 10.1%

Cohort is trading below its estimated future cash flow value (£12.5) at £11.24, indicating it may be undervalued based on cash flows. Analysts expect earnings to grow significantly at 20.23% annually, outpacing the UK market’s 11.9%. Despite a low forecasted Return on Equity of 15.5%, Cohort’s revenue growth (7.2%) surpasses the market average (4.5%). Recent contract wins, such as a €42.3 million deal with the Portuguese Navy, bolster its financial outlook.

AIM:CHRT Discounted Cash Flow as at May 2026

Overview: National Atomic Company Kazatomprom JSC is involved in the exploration, production, processing, marketing, and sale of uranium and related products with a market cap of $18.69 billion.

Operations: The company’s revenue primarily comes from its Uranium segment, generating KZT 1.64 trillion, and the UMP segment, contributing KZT 90.64 billion.

Estimated Discount To Fair Value: 21.7%

National Atomic Company Kazatomprom JSC is trading at a good value, with its current price ($69.7) below the estimated future cash flow value of $89. Although revenue growth is forecasted at 12.5% annually, slower than 20%, it still surpasses the UK market average of 4.5%. Earnings are projected to grow faster than the UK market at 13.9% per year, despite a decrease in profit margins from last year and reduced U3O8 sales volumes recently reported for Q1 2026.

LSE:KAP Discounted Cash Flow as at May 2026
LSE:KAP Discounted Cash Flow as at May 2026

Overview: Marks and Spencer Group plc operates a range of retail stores and has a market cap of approximately £6.49 billion.

Operations: The company generates revenue through its International segment, which amounts to £624.50 million.

Estimated Discount To Fair Value: 48.2%

Marks and Spencer Group is trading at £3.2, significantly below its estimated future cash flow value of £6.18, indicating it may be undervalued based on cash flows. Despite a decline in profit margins from 3.8% to 0.1%, earnings are forecasted to grow substantially at 26.3% annually, outpacing the UK market average of 11.9%. Analysts agree on a potential stock price increase by 32%, though large one-off items affect financial results.

LSE:MKS Discounted Cash Flow as at May 2026
LSE:MKS Discounted Cash Flow as at May 2026

Key Takeaways

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AIM:CHRT LSE:KAP and LSE:MKS.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *